Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects

NCT06323655 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Tasimelteon
DRUG: Active Control Placebo
DRUG: Tasimelteon Placebo
DRUG: Active Control

Sponsor

Vanda Pharmaceuticals